Literature DB >> 6134351

HLA-DR MT and MB antigens in Takayasu disease.

F Numano, I Isohisa, M Egami, N Ohta, T Sasazuki.   

Abstract

Recent studies on the pathogenesis of Takayasu disease have focussed on the participation of genetic factors, and HLA analysis has confirmed the close relationship between Takayasu disease and HLA Bw52. In an attempt to investigate the association of immune response gene with the disease, HLA-DR (DR-1, -2, -3, -4, -5, -w6, -7, -w8, -w9, -w10), MT (-1, -2, -3), MB (-1, -3) antigens were studied in 52 patients with Takayasu disease and the data compared with findings in healthy Japanese. As there were no statistical differences between the two groups in the frequencies of all these antigens, genetic factors in Takayasu disease may be much more closely associated with B than with D loci.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6134351     DOI: 10.1111/j.1399-0039.1983.tb00159.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Angiographic morphology in nonspecific aortoarteritis (Takayasu's arteritis): a study of 126 patients from north India.

Authors:  S Sharma; M Rajani; K K Talwar
Journal:  Cardiovasc Intervent Radiol       Date:  1992 May-Jun       Impact factor: 2.740

Review 2.  Hereditary factors of Takayasu arteritis.

Authors:  F Numano
Journal:  Heart Vessels Suppl       Date:  1992

Review 3.  Revisited HLA and non-HLA genetics of Takayasu arteritis--where are we?

Authors:  Chikashi Terao
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

4.  Takayasu's disease in Arabs.

Authors:  M A Sattar; A G White; B Eklof; F F Fenech
Journal:  Postgrad Med J       Date:  1985-05       Impact factor: 2.401

5.  Seronegative spondarthritis associated with Takayasu's arteritis.

Authors:  M Magaro'; L Altomonte; L Mirone; A Zoli; G Corvino
Journal:  Ann Rheum Dis       Date:  1988-07       Impact factor: 19.103

6.  HLA typing of Takayasu arteritis in Korea.

Authors:  M H Park; Y B Park
Journal:  Heart Vessels Suppl       Date:  1992
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.